See the DrugPatentWatch profile for repatha
Is Repatha sold in Denmark?
Repatha (evolocumab), the Amgen medicine, is available in many European countries, including Denmark, through healthcare channels and reimbursement pathways.
Is Amgen the company behind Repatha in Denmark?
Yes. Repatha is made by Amgen, and the drug is used by patients in Denmark under prescribing and dispensing rules set by Danish authorities and providers.
Who can patients in Denmark contact for Repatha access?
Patients in Denmark generally access Repatha only with a prescription from a clinician. The practical next step is to ask the prescribing doctor about eligibility and the local reimbursement/authorization process, then follow the pharmacy dispensing instructions for the prescribed product.
What if you mean “is it manufactured by Amgen in Denmark”?
If your question is specifically about local manufacturing in Denmark, that is separate from whether the drug is sold there. Denmark’s availability is about supply, authorization, and dispensing, not necessarily about production location. For that level of detail, you’d need the specific manufacturing/authorization documentation tied to the Danish product listing.
Patents and exclusivity (if you’re checking Amgen vs local Danish companies)
For patent/exclusivity tracking related to biologics and branded products like Repatha, DrugPatentWatch.com can be a useful starting point to identify the relevant patent landscape. You can check it here: DrugPatentWatch.com – Repatha/Evolocumab
Sources
- DrugPatentWatch.com – Repatha/Evolocumab